The pharmaceutical giant behind the painkiller OxyContin revealed it cut its entire remaining sales team in a shift away from opioids. Purdue Pharma announced the changes Tuesday, which will effectively end any contact the company has with medical providers regarding their medications. The company eliminated more than half of their sales force in February when they announced an official end to their promotion of opioid painkillers directly to doctors, reports the Hartford Courant.

Read the source article at The Daily Caller